Literature DB >> 7237869

Severe renal failure in multiple myeloma.

F G Cosio, T V Pence, F L Shapiro, C M Kjellstrand.   

Abstract

Twenty-four patients with multiple myeloma and renal failure severe enough to require dialysis were retrospectively analyzed. Most patients initially presented with renal failure and multiple myeloma was subsequently diagnosed. Intravenous pyelography precipitated irreversible renal failure in 2 patients. Absence of light chain disease and treatment with peritoneal dialysis were associated with increased recovery of renal fraction. The one year survival rate of myeloma patients on chronic dialysis was similar to the general myeloma population but was much worse than a group of age matched non-myeloma chronic dialysis patients. Survival rate was diminished in patients with elevated serum calcium levels.

Entities:  

Mesh:

Year:  1981        PMID: 7237869

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma.

Authors:  Mufazzal Ahmad
Journal:  Int Urol Nephrol       Date:  2007-01-13       Impact factor: 2.370

2.  The cost of chronic dialysis in multiple myeloma.

Authors:  R A Coward
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

3.  Analysis and management of renal failure in fourth MRC myelomatosis trial. MRC working party on leukaemia in adults.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

4.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; A P Maxwell; I Bruce; B G Murphy; C C Doherty
Journal:  Ir J Med Sci       Date:  1993-06       Impact factor: 1.568

5.  Should patients with renal failure associated with myeloma be dialysed?

Authors:  R A Coward; N P Mallick; I W Delamore
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

Review 6.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; C C Doherty
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

7.  [Successful treatment of kappa light chain nephropathy using membrane plasma separation].

Authors:  K B Sprenger; J Galle; I Sprenger-Klasen; J M Herrmann; H E Franz
Journal:  Klin Wochenschr       Date:  1984-10-01

8.  Clinical profile of kidney involvement preceding diagnosis of multiple myeloma; a single center experience.

Authors:  Manish R Balwani; Manoj R Gumber; Pankaj R Shah; Vivek B Kute; Himanshu V Patel; Divyesh P Engineer; Dinesh N Gera; Umesh Godhani; Rajesh Singh Gautam; Hargovind L Trivedi
Journal:  J Nephropharmacol       Date:  2015-03-29

9.  Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.

Authors:  Anne-Pascale Meert; Sebastian Wittnebel; Stéphane Holbrechts; Anne-Claire Toffart; Jean-Jacques Lafitte; Michael Piagnerelli; France Lemaitre; Olivier Peyrony; Laurent Calvel; Jean Lemaitre; Emmanuel Canet; Alexandre Demoule; Michael Darmon; Jean-Paul Sculier; Louis Voigt; Virginie Lemiale; Frédéric Pène; David Schnell; Etienne Lengline; Thierry Berghmans; Laurence Fiévet; Christiane Jungels; Xiaoxiao Wang; Ionela Bold; Aureliano Pistone; Adriano Salaroli; Bogdan Grigoriu; Dominique Benoit
Journal:  Intensive Care Med       Date:  2021-09-20       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.